Most Recent
Lundbeck’s decade-long damages bid against Sandoz stayed despite High Court win
Novartis unit Sandoz has won its bid to stay a case by rival Lundbeck, including orders for damages previously calculated at $26.3 million and counting, despite having succeeded at the High Court in a dispute over its patent for blockbuster antidepressant Lexapro.
Misconduct exception doesn’t apply in Uber class action privilege fight
In the latest skirmish over documents in two class actions, Uber has mostly won a bid to shield almost 150 documents on the grounds of privilege, with a judge finding the misconduct exception that has previously bedevilled the rideshare giant did not apply.
Sour grapes as Champagne growers appeal trade mark decision
The French association representing wine producers from Champagne is appealing a recent trade mark loss to an Australian health retailer, claiming a product being sold on Aussie shelves is using its coveted name without assurances it originates from the French region. 
Sanofi defeats government’s $325M appeal over generic Plavix ban
Drug maker Sanofi-Aventis is not liable for the federal government’s losses for excess subsidies paid for the blood-thinner Plavix after an allegedly unjustified court injunction prevented the release of a generic version of the blockbuster drug, an appeals court has found.
Seven tries to resurrect ‘7Now’ mark in IP stoush with 7-Eleven
Seven Network has appealed a ruling that revoked its 7NOW trade mark for non-use in a victory for convenience chain 7-Eleven as it seeks to expand its presence in Australia.
ACCC’s rejection of $1.8B Telstra, TPG deal stands on appeal
Telstra and TPG have lost their challenge to the ACCC’s decision refusing authorisation for a $1.8 billion regional network sharing agreement, with the Australian Competition Tribunal finding the deal would increase Telstra's dominance in the mobile phone market. 
Facing ‘staggeringly large’ security costs, class action queries separate lawyers for Blue Sky execs
The applicant in a class action against Blue Sky Alternative Investments and auditor EY has raised an “often overlooked” principle to challenge the separate legal representation of two of the company’s directors, dodging applications for almost $15 million in security – for now.
Court approves $6.3M class action settlement against Linchpin directors
A judge has approved a settlement with former directors of collapsed advisory firm Linchpin Capital under which insurer RiverStone will pay $6.3 million, which will be used to fund the investor class action’s claims against AIG.
$47M settlement in ANZ credit insurance class action reasonable, judge says
A $47 million settlement in a class action against ANZ -- one of three settlements in a series of class actions against the big banks over 'junk' consumer credit insurance -- was fair and reasonable, a judge has said.
Judge signals approval of class action settlement with Linchpin directors
A settlement with directors in an investor class action brought over the collapse of advisory firm Linchpin Capital is in the interests of group members, a judge has said.